RemeGen Co., Ltd. (Yantai) was co-founded in 2008 by Mr. Wang Weidong, founder of Rongchang Pharmaceuticals, and Dr. Jianmin Fang a Canadian-American scientist. RemeGen is headquartered in Yantai, Shandong Province, China, with R&D centers and offices in China and the United States.
The World’s First Innovative Dual-Target Biological Medication to Treat Systemic Lupus Erythematosus
The First Independently Developed Novel ADC Drug in China
【2024.05.07】 Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
【2024.04.26】 [Overseas Regulatory Announcement - Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
The 2026 World Conference on Lung Cancer (WCLC 2026) was held in Seoul, South Korea, on September 12 to 15, 2026 (GMT +9). As the world's largest academic conference on lung cancer research, WCLC brought together experts and researchers from over
Address: No. 58 Beijing Middle Road, Yantai Development Zone, Shandong, China.
Telephone:(+86)535-3573511
Join Us
Release date:2025.10.28
At RemeGen Biosciences, our culture defines how we work, grow, and innovate together. Guided by our values, we create an environment where every employee can thrive and contribute to meaningful breakthroughs for patients.
Back